Approach and management of checkpoint inhibitor-related immune hepatitis

Research output: Contribution to journalArticle

9 Scopus citations

Abstract

Immune checkpoint inhibitors have promising clinical activity across multiple gastrointestinal cancers and immune-mediated hepatotoxicity is particularly relevant for this group of patients. In this article we will review the recognition, workup and management of suspected checkpoint inhibitor related immunehepatitis.

Original languageEnglish (US)
Pages (from-to)220-224
Number of pages5
JournalJournal of Gastrointestinal Oncology
Volume9
Issue number1
DOIs
Publication statusPublished - Feb 1 2018

    Fingerprint

Keywords

  • Gastrointestinal cancers
  • Immune checkpoint inhibitors
  • Immune-mediated toxicity
  • Immunotherapy

ASJC Scopus subject areas

  • Oncology
  • Gastroenterology

Cite this